Company / Return on Assets (ROA)
GYRE THERAPEUTICS, INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
5.9%
FY2025
5-year range
-158.0% / 14.3%
FY2021-FY2025
Trend
-58.3%
vs FY2024
Sector context
#36 of 213
Health Care
What the data says
GYRE THERAPEUTICS, INC.'s return on assets (roa) of 5.9% is higher than 83% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -158.0% in FY2021 to 14.3% in FY2024.
Based on SEC 10-K filings.
5.9% in FY2025 with a 5-year CAGR of +64.1%. Top quartile in the Health Care sector.
Improved from 3.7% to 5.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +0.9pp
- 5-Year Change
- +64.1pp
- 10-Year Change
- -
Sector benchmark
+124.6% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 58.3% year-over-year.
- Currently 30.1pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 5.9% | -58.3% |
| FY2024 | 14.3% | +285.7% |
| FY2023 | 3.7% | -27.3% |
| FY2022 | 5.1% | +103.2% |
| FY2021 | -158.0% | -171.5% |
| FY2020 | -58.2% | -3.9% |
| FY2019 | -56.0% | -224.4% |
| FY2018 | -17.3% | +68.4% |
| FY2017 | -54.6% | -22.7% |
| FY2016 | -44.5% | -109.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026